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Objectives: The aim of this study was to investigate the prevalence and explore the
predictors and early outcomes of post-operative delirium (POD) in patients with type A
aortic dissection (AAD) during intensive care unit (ICU) stays.
Methods: We retrospectively reviewed the records of 301 patients with AAD who
underwent surgical treatment in our institution from January 2017 to December 2018.
Results: Delirium developed in 73 patients (24.25%) during the ICU stay. Patients with
lower estimated glomerular filtration rates [odds ratio (OR) 0.84, 95% CI 0.74–0.94,
p = 0.003], post-operative midazolam use (OR 2.37, 95% CI 1.33–4.23, p = 0.004),
and post-operative morphine use (OR 1.87, 95% CI 1.07–3.29, p = 0.029) were more
susceptible to developing POD. Patients who developed POD had a longer ICU stay
(11.52 vs. 7.22 days, p < 0.001) and hospital stay (23.99 vs. 18.91, p = 0.007) with
higher hospitalization costs (48.82 vs. 37.66 thousand dollars, p < 0.001) than those
without POD. The in-hospital mortality rate was higher in the delirium group, but the
difference was not significant (6.85 vs. 4.82%, p = 0.502).
Conclusions: The incidence of POD in patients with AAD was high and was associated
with renal dysfunction and the use of midazolam andmorphine. PODwas associated with
poor early outcomes, suggesting the importance of early screening, such as for renal
dysfunction, and prevention by using sedation scales to minimize the use of midazolam
and morphine in these patients.
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INTRODUCTION
Post-operative delirium (POD) is common in patients
undergoing elective cardiac surgery, including aortic valve
replacement and coronary artery bypass grafting (CABG). The
reported incidence of elective cardiac surgery varies between
3 and 17.3% (1–4). Type A aortic dissection (AAD) is a life-
threatening condition requiring surgical intervention (5, 6).
As both the disease itself and intraoperative deep hypothermic
circulatory arrest might cause ischemia to the cerebral circulation
and nervous system, patients with AAD might have a greater
risk of developing neuropsychiatric complications than patients
undergoing other cardiac surgeries (7, 8). Due to the stress of
surgery and the typical environment, post-operative patients
in intensive care units (ICUs) have higher incidence rates of
POD than other patients (9). Although diagnostics and surgical
techniques have significantly improved, the post-operative
neurological morbidity rate in AAD patients remains high (10).
POD is associated with several negative outcomes, including
elevated morbidity and mortality, prolonged ICU stay, and extra
medical expenses (11–13).
POD is a common neuropsychiatric disorder in AAD patients,
but studies focusing on the potential effects of POD among these
patients are sparse. Several studies have demonstrated a high
prevalence of POD among these patients and raised concerns
about delirium prevention in this population. However, the
risk factors reported was diverse, and these studies are limited
by small sample size (10, 14, 15). Due to the particularity of
disease and surgery, the characteristics of POD in AAD patients
might be quite different from other patients of cardiac surgery.
The predictors and prognosis still need to be further explored
to offer evidence for POD prevention, and help find out the
perniciousness of POD in these patients. In this study, we aimed
to explore the prevalence, predictors, and early outcomes of POD
in patients with AAD during the ICU stay.
MATERIALS AND METHODS
Design
This is a retrospective cohort study. The study has been reported
following the STROBE guidelines for observational studies (16).
Ethical approval was obtained from the institutional review
board. The requirement for informed consent was waived
because of the retrospective nature of the study.
Setting
This study was conducted in a 39-bed cardiac surgery ICU
of a tertiary hospital. The cardiac surgery ICU admits ∼4,800
post-operative patients per year, including 150–200 patients
with AAD.
Study Population
We retrospectively reviewed patients who underwent surgical
treatment for AAD from January 2017 to December 2018. The
diagnosis of AAD was determined according to CT angiography.
We excluded patients who had delirium or chronic schizophrenia
before surgery. We also excluded patients who were unable to be
diagnosed with POD due to missing data. Finally, 301 patients
were included in this study (Figure 1).
Data Collection
The primary outcome was POD, which was defined as a
minimum of one positive assessment using the Confusion
Assessment Method–ICU (CAM-ICU) tool during the ICU stay.
The CAM-ICU defines delirium if at least two features of the
CAM-ICU are present (Features 1 and 2 OR 3 and 4) (17, 18).
In addition, we also used treatment with olanzapine as a proxy
for the diagnosis of delirium because in the ICU of our hospital,
we used olanzapine only to treat delirium.
The pre-operative data were retrospectively reviewed and
analyzed. Surgery within 24 h from the onset of symptoms was
considered emergent surgery. In-hospital mortality was defined
as death occurring during the post-operative hospital stay. The
estimated glomerular filtration rate (eGFR) was used to assess
renal function after surgery. The eGFR was classified into four
groups: normal (eGFR >90 ml/min/1.73 m2), mild (eGFR 60–90
ml/min/1.73 m2), moderate (eGFR 30–60 ml/min/1.73 m2), and
severe (eGFR <30 ml/min/1.73 m2).
Operative Technique
All operations were performed through a mid-sternotomy.
Total arch replacement combined with stented elephant trunk
(SET) implantation was the primary surgical strategy in our
hospital. Other techniques used along or in combination were
the Bentall procedure, David I procedure, or CABG. All patients
received standard transcutaneous cerebral oximetry monitoring
and transesophageal echocardiography during surgery.
Statistical Analysis
The primary end point is the incidence of POD. The rule of
thumb in logistic modeling is that a minimum of ten events per
predictor variable should be achieved based on simulation studies
(19). We used the lowest incidence 34% (14) and ten valuables in
logistic model to estimate the sample size of 294.
Data are presented as the mean and SD or median
(interquartile range) for continuous variables and as percentages
for categorical variables. We log transformed the N-terminal
prohormone of brain natriuretic peptide (NT-proBNP) level
because it had a right-skewed distribution. Normally distributed
continuous variables were compared using one-way ANOVA.
The Pearson χ2-test was applied to all categorical variables.
Logistic regression models were used to investigate univariable
and multivariable risk factors for POD. In the logistic regression
analysis, potential predictors of POD were tested in a univariable
fashion, and variables with p-values < 0.1 were included
in the multivariable analysis. In the multivariable analysis, a
backwards stepwise model was used. The results of the logistic
regression analysis are presented as odds ratios (ORs) with the
corresponding 95%CIs. The analyses were performed using SPSS
version 22.0 (IBM, New York, NY) and R statistical software (R,
version 3.5.1; R Project).
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FIGURE 1 | Flow diagram of patient selection.
RESULTS
Patient Characteristics
A total of 365 cases have been reviewed and after exclusion
34 patients who did not receive surgery, seven patients
who presented with pre-operative delirium or had chronic
schizophrenia, 17 patients with incomplete data to identify POD,
and six patients with incomplete risk factor data. Data from 301
cases were analyzed (Figure 1).
The patients were divided into two groups according to
whether they developed POD during the ICU stay. The
demographic characteristics and perioperative factors of the
non-delirium group and delirium group are shown in Table 1.
The mean participant age was 50.66 (SD 12.24), and 79.40%
were males. The incidence of POD was 24.25% in awake
AAD patients after surgery. The incidence of POD was
23.83% (56/235) in males, whereas in females, the incidence
was 25.76% (17/66). Patients with delirium had more post-
operative blood transfusions, higher eGFRs, and higher blood
urea nitrogen, NT-proBNP, and blood calcium levels than
those without delirium. In addition, more patients in the
delirium group received midazolam, dexmedetomidine, and
morphine post-operatively than those in the non-delirium
group (Table 1).
Predictors of POD
The results of the univariate and multivariate logistic regression
analysis for the predictors of POD are presented inTable 2. In the
univariate analysis, variables with a p-value < 0.1 were included
in the multivariable analysis. In the multivariate analysis, a lower
eGFR (OR 0.84, 95% CI 0.74–0.94, p = 0.003), post-operative
use of midazolam (OR 2.37, 95% CI 1.33–4.23, p = 0.004), and
post-operative use of morphine (OR 1.87, 95% CI 1.07–3.29, p
= 0.029) were independent predictors of the development of
POD among AAD patients. Figure 2 shows the incidence of POD
in different groups divided by the independent predictors. We
found that patients who used morphine after surgery presented a
higher incidence of POD than those who did not use morphine
(32.12 vs. 17.68%, p = 0.004). In addition, patients who received
midazolam had a higher incidence of POD than those who did
not (40.48 vs. 17.97%, p < 0.001). Patients were classified into
four groups according to eGFR to assess renal function after
surgery. The incidence of POD showed a significant increase as
renal function declined (p for trend is <0.001).
Early Outcomes
The comparison of early outcomes during hospitalization
between the delirium group and the non-delirium group is shown
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TABLE 1 | Demographic characteristics and perioperative factors of delirium and non-delirium group.
Variables Total (n = 301) Non-delirium group (n = 228) Delirium group (n = 73) P-value
Demographic characteristics
Age, years 50.66 ± 12.24 50.46 ± 12.32 51.27 ± 12.08 0.627
Male, n (%) 235 (78.01) 179 (78.51) 56 (76.71) 0.747
Hypertension, n (%) 202 (67.11) 151 (66.23) 51 (69.86) 0.668
Diabetes mellitus, n (%) 12 (3.99) 11 (4.82) 1 (1.37) 0.305
Nicotine use, n (%) 53 (17.61) 36 (15.79) 17 (23.29) 0.159
Alcohol use, n (%) 16 (5.32) 10 (4.39) 6 (8.22) 0.231
Surgical details
Emergency operation, n (%) 70 (23.26) 53 (23.25) 17 (23.29) 0.994
Total arch replacement, n (%) 280 (93.02) 212 (92.98) 68 (93.15) 0.961
Stented elephant trunk, n (%) 269 (89.37) 203 (89.04) 66 (90.41) 0.740
Bentall procedure, n (%) 37 (12.29) 24 (10.53) 13 (17.81) 0.099
David I procedure, n (%) 24 (7.97) 15 (6.58) 9 (12.33) 0.114
CABG, n (%) 13 (4.32) 8 (3.51) 5 (6.85) 0.222
Duration of surgery, min 476.91 ± 89.65 471.92 ± 84.96 492.49 ± 102.02 0.088
CPB time, min 198.34 ± 42.69 196.72 ± 40.42 203.40 ± 49.07 0.245
Aorta cross-clamp time, min 114.86 ± 30.16 114.61 ± 29.69 115.64 ± 31.79 0.798
Intraoperative blood transfusion, n (%) 263 (87.38) 197 (86.40) 66 (90.41) 0.425
Post-operative factors
APACHE II score 9.85 ± 5.97 9.51 ± 6.02 10.92 ± 5.72 0.080
EuroScore 5.64 ± 2.74 5.57 ± 2.81 5.88 ± 2.49 0.399
Post-operative blood transfusion, n (%) 110 (36.54) 74 (32.46) 36 (49.32) 0.012
Post-operative laboratory tests
Hemobilirubin, µmol/L 38.58 ± 22.28 39.13 ± 21.97 36.86 ± 23.32 0.450
Blood albumin, g/L 33.96 ± 5.24 34.09 ± 5.43 33.56 ± 4.61 0.457
BUN, mmol/L 12.15 ± 4.70 11.73 ± 4.48 13.46 ± 5.15 0.006
CRE, µmol/L 158.96 ± 102.93 149.34 ± 95.66 189.00 ± 118.69 0.004
eGFR, ml/min/1.73 m2 54.71 ± 27.67 58.09 ± 28.39 44.15 ± 22.36 <0.001
Normal group (eGFR >90) 45 (14.95%) 43 (95.56%) 2 (4.44%)
Mild group (eGFR 60–90) 73 (24.25%) 57 (78.08%) 16 (21.92%)
Moderate group (eGFR 30–60) 124 (41.20%) 89 (71.77%) 35 (28.23%)
Severe group (eGFR <30) 59 (19.60%) 39 (66.10%) 20 (33.90%) 0.003
cTNT, ng/ml 0.56 (0.38, 1.06) 0.53 (0.36, 0.94) 0.71 (0.44, 1.45) 0.071
NT-proBNP, log transformed pg/ml 6.55 ± 1.07 6.48 ± 1.01 6.77 ± 1.20 0.040
Hemoglobin, g/L 9.70 ± 4.06 9.83 ± 4.57 9.29 ± 1.60 0.321
Blood sodium, mmol/L 139.23 ± 3.99 139.17 ± 4.37 139.88 ± 4.05 0.054
Blood potassium, mmol/L 3.81 ± 0.60 3.86 ± 0.62 3.63 ± 0.46 0.714
Blood calcium, mmol/L 0.94 ± 0.19 0.95 ± 0.22 0.91 ± 0.08 0.022
Post-operative sedatives
Midazolam, n (%) 84 (27.91) 50 (21.93) 34 (46.58) <0.001
Dexmedetomidine, n (%) 261 (86.71) 192 (84.21) 69 (94.52) 0.024
Remifentanil, n (%) 116 (38.54) 82 (35.96) 34 (46.58) 0.105
Fentanyl, n (%) 5 (1.66) 5 (2.19) 0 (0.00) 0.453
Morphine, n (%) 137 (45.51) 93 (40.79) 44 (60.27) 0.004
Propofol, n (%) 269 (89.37) 200 (87.72) 69 (94.52) 0.155
Data presented as mean ± SD for continuous variables and percentage for discontinuous variables. CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass; APACHE,
acute physiology and chronic health evaluation; BUN, blood urea nitrogen; CRE, serum creatinine; eGFR, estimated glomerular filtration rate; NT-proBNP, N-terminal prohormone of
brain natriuretic peptide.
in Table 3. Patients with POD had a longer ICU stay (11.52 vs.
7.22 days, p < 0.001) and hospital stay (23.99 vs. 18.91, p =
0.007) than those without POD. In addition, patients with POD
had higher medical expenses than those without POD (48.82 vs.
37.66 thousand dollars, p< 0.001). The in-hospital mortality rate
was higher in the delirium group than in the non-delirium group,
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TABLE 2 | Perioperative risk factors for POD identified by the logistic regression analysis.
Variables Univariable analysis Multivariable analysis*
OR 95% CI P-value OR 95% CI P-value
Duration of surgery, min 1.00 1.00–1.01 0.089 – – –
APACHE II score 1.04 1.00–1.09 0.082 – – –
Post-operative blood transfusion, n (%) 2.03 1.19–3.46 0.010 – – –
BUN, mmol/L 1.08 1.02–1.14 0.009 – – –
NT-proBNP, log transformed pg/ml 1.29 1.01–1.65 0.042 – – –
Blood sodium, mmol/L 1.07 1.00–1.14 0.056 – – –
Blood calcium, mmol/L 0.01 0.00–0.33 0.011 0.04 0.00–1.83 0.100
eGFR, per 10 ml/min/1.73 m2 increase 0.81 0.73–0.91 <0.001 0.84 0.74–0.95 0.005
Midazolam 3.10 1.78–5.42 <0.001 2.35 1.31–4.22 0.004
Morphine 2.20 1.29–3.77 0.004 1.83 1.04–3.24 0.037
OR, odds ratio; APACHE, acute physiology and chronic health evaluation; BUN, blood urea nitrogen; NT-proBNP, N-terminal prohormone of brain natriuretic peptide; eGFR, estimated
glomerular filtration rate.
*The model was adjusted by age and gender.
but the difference was not statistically significant (6.85 vs. 4.82%,
p= 0.502).
DISCUSSION
In this study, we found that 24.25% of patients with AAD
developed POD during the ICU stay. A lower eGFR and the
use of midazolam and morphine after surgery were independent
predictors of POD. As a result, patients with PODhad longer ICU
stays and hospital stays and higher medical expenses than those
without POD.
Because AAD is a very emergent and life-threatening disease,
most surgeons pay attention to mortality while ignoring post-
operative neurological symptoms. However, with improvements
in surgical techniques, an increasing number of patients
survive after surgery. Thus, post-operative morbidity should be
emphasized, as it may directly influence patient outcomes and
quality of life. As one of the most severe and complex surgical
complications of cardiac vascular disease, POD was frequently
observed in our clinical practice. However, although several
studies have reported the incidence and risk factors for POD
after cardiac surgeries, few have focused on AAD patients. In
previous studies, the reported incidence of POD after cardiac
surgery varied between 3 and 17.3% (1–4, 20). Gaul et al. found
that POD is the most common neurological complication in
patients with AAD, accounting for 31.9% of all neurological
complication events (10). Liu et al. (14) also reported that the
incidence of POD in 100 AAD patients reached 34%. Shi et al.
(15) stated an incidence of 45.95% in 148 AAD patients. These
studies indicated a higher incidence of POD amongAADpatients
than among other patients. However, these investigations were
limited by small sample sizes. Our study enrolled more than
300 AAD patients and collected detailed data to show that POD
affected up to 24.25% of AAD patients after surgery and could
help raise awareness of POD management for AAD patients in
clinical practice.
Because the mechanism of delirium is unknown, an effective
treatment is still lacking at present. Many studies have attempted
to identify modifiable and non-modifiable risk factors to
detect and prevent the development of delirium early. Clinical
practice guidelines describe that benzodiazepine use and blood
transfusions are the only two modifiable risk factors for delirium
in critically ill adults with strong evidence support (21). In our
study, we only found that post-operative blood transfusion was
associated with POD in the univariate analysis, but it was not
significant in the multivariate analysis. However, avoiding blood
transfusions and receiving lower levels of hemoglobin is still
controversial (22). In addition, we also found that the use of
midazolam andmorphine were independent risk factors for POD
in AAD patients. Our results also confirmed the associations
between delirium and benzodiazepine and opioid use in AAD
patients. Furthermore, we identified that a lower eGFR was an
independent risk factor for POD in AAD patients. A systematic
review including 34 articles demonstrated that the association
between renal dysfunction and delirium after on-pump cardiac
surgery was inconclusive (23). Our study showed a positive
relationship between post-operative renal dysfunction and the
development of POD among the AAD population. The incidence
of POD significantly increased as the degree of renal function
declined. In contrast to previous studies involving patients with
other diseases, we did not find any relationship between older age
and delirium in AAD patients (23). Furthermore, two studies that
included AAD patients showed that age is not an independent
risk factor for POD, which was consistent with our results
(14, 24).
Many studies have documented that POD is associated with
several negative clinical consequences, including major post-
operative complications, longer hospital stays with increased
costs, and higher mortality (12, 13, 25). However, despite the
emergent nature of AAD and high mortality in patients with
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FIGURE 2 | Incidence of post-operative delirium in different groups divided by the independent determinants.
TABLE 3 | The early outcomes of patients with and without POD.
Delirium group (n = 73) Non-delirium group (n = 228) Mean difference 95% CI P-value
Post-operative ICU LOS, days 11.52 ± 10.14 7.22 ± 8.17 4.30 ± 1.19 1.97–6.64 <0.001
Post-operative hospital LOS, days 23.99 ± 16.18 18.91 ± 13.00 5.08 ± 1.86 1.41–8.47 0.007
Hospital costs, thousand dollars 48.82 ± 23.95 37.66 ± 17.12 11.16 ± 2.55 6.14–16.19 <0.001
In-hospital mortality, n (%) 5 (6.85) 11 (4.82) 2.03% 0.044–0.085 0.502
Data presented as mean ± SD for continuous variables and percentage for discontinuous variables. LOS, length of stay; ICU, intensive care unit.
AAD, only a few studies have focused on POD in these patients.
In our study, we further compared the early outcomes of patients
with and without POD. The results showed that patients with
POD had a longer ICU length of stay and longer hospital length
of stay than those without POD. As a consequence, the hospital
costs for patients with POD are much higher than those for
patients without POD. Contrary to previous studies on other
populations, our study showed that the mortality rate was higher
in the delirium group than in the non-delirium group, but the
difference was not statistically significant. This result might be
influenced by the exclusion of patients who were deeply sedated
or in a coma, who were the most severe patients, which may
underestimate the reported mortality rate. Although we did not
find a positive association between POD and post-operative
hospital mortality in this study, the longer hospital stay and
higher medical costs showed that POD burdens patients and
hospitals to some extent. Further prospective studies and follow-
up evaluations are required to assess mid-term and long-term
patient outcomes.
We acknowledge the potential limitations of our study. First,
this study was limited by its observational and retrospective
nature. Second, our participants were from a single hospital,
so the generalizability of the findings remains to be confirmed.
Third, the incidence of delirium might be underestimated as
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a result of missed diagnoses because delirium status changes
over time. However, we also used olanzapine as a proxy
for the diagnosis of delirium. Further studies are required
to conduct a prospective and multicenter investigation to
elucidate the prevalence and clinical outcomes of POD among
AAD patients.
CONCLUSION
In summary, our findings showed that patients with AAD had
a higher incidence of POD during the ICU stay than those
without AAD. Patients with lower eGFRs who used midazolam
and morphine after surgery were more susceptible to developing
POD. Patients who developed POD had a longer ICU stay
and hospital stay with higher hospitalization costs than those
without POD. More attention should be paid to POD in patients
with AAD. Early screening, such as for renal dysfunction, and
prevention by using nurse-led sedation scales and protocols to
minimize the use of sedative medication might contribute to
improving the clinical outcomes of these patients during and after
the ICU stay.
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